About MPD-RC


The Myeloproliferative Disorders Research Consortium (MPD-RC) is an international, multi-institutional non profit consortium funded by the National Cancer Institute and set up to coordinate, facilitate, and perform basic and clinical research investigating the genetic and cellular mechanisms of the Philadelphia Chromosome (Ph) negative myeloproliferative neoplasms (MPNs). The ultimate goal is to develop novel therapeutic strategies to improve the management of patients with this type of diseases. More

Info for Patients

Find out more about Myeloproliferative Neoplasms, their symptoms, diagnosis and treatment. More

Find patient support group and share your experience with other patients and their families. More

New Trial: MPD-114!


We are now recruiting subjects for the trial MPD-RC 114: Exploring the Potential of Dual Kinase JAK 1/2 Inhibitor Ruxolitinib (INC424) with Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis.

» 114 Protocol on ClinicalTrials.gov
superadmin on November 13 2013 10:00:11 · Read More · 230 Reads · Print



We are recruiting patients to the study 111.

»111 Protocol on ClinicalTrials.gov
superadmin on October 27 2011 14:34:41 · Print



We are recruiting patients for the clinical trial 112.

»112 Protocol on ClinicalTrials.gov
superadmin on September 24 2011 00:00:00 · Print